• Novel Prognostic Classification of AML

  • Precision Medicine

  • Minimal Residual Disease

  • Bioinformatics

  • Genomics-related Ethical, Economic and Legal Support

The Leucegene project will help pave the way for a new era in personalized medicine and offer patients better targeted therapies


The Leucegene team utilises Next-Generation sequencing, chemogenomic and precision medicine approaches to develop innovative tools, treatments and collaborations to cure AML.

Health Care Providers

We have developed a new prognostic test and look to drive implementation through socio-economic studies and clinician engagement.


Our Leucegene approach will refine precision medicine in AML and provide cures for this disease.

Latest News

Leucegene Team is now recruiting

The leucegene team is currently seeking highly motivated doctoral…

New publication in Blood

H3K27M/I mutations promote context-dependent transformation in…

New publication in Clinical Cancer Research

Chemogenomic landscape of RUNX1-mutated AML reveals importance…

Upcoming Events

Our Partners